Blog

Genotyping vs Sequencing: What’s the Difference and When to Use Each?

Genotyping vs Sequencing: What’s the Difference and When to Use Each?

When comparing genotyping vs sequencing, researchers must decide how deeply they need to analyze genetic variation. Genotyping identifies known genetic variants at predefined positions in the genome, while DNA sequencing reads the exact nucleotide order to uncover both known and novel variation. The right choice depends on whether the study aims to validate known markers at scale or to discover new variants.

This guide explains what genotyping is, what DNA sequencing is, how genotyping by sequencing (GBS) bridges the two approaches, and how to choose the most cost-effective method for plant breeding, biomedical research, and high-throughput screening.

What Is Genotyping?

Genotyping is a molecular biology method that identifies specific DNA variants at known positions in the genome. Rather than determining the complete DNA sequence, genotyping analyzes predefined genetic markers, most commonly single nucleotide polymorphisms (SNPs) and insertions/deletions (Indels), to determine which alleles are present in an individual sample.

In the context of genotyping vs sequencing, genotyping is a targeted approach. It answers a focused question: Does this sample contain a specific genetic variant? DNA sequencing, by contrast, reads the exact nucleotide order of a DNA fragment or entire genome, enabling the discovery of both known and novel variants.

How Genotyping Works

Most modern SNP genotyping assays rely on PCR-based amplification of specific genomic regions. Techniques such as allele-specific PCR, TaqMan assays, microarrays, and competitive allele-specific PCR methods like PACE® (PCR Allele Competitive Extension) detect variant-specific signals with high accuracy.

Because only selected loci are analyzed, genotyping is:

  • Highly scalable for large populations
  • Faster than full DNA sequencing
  • Cost-efficient for screening known markers
  • Reproducible across repeated experiments

This makes it particularly valuable in high-throughput environments.

What Is Genotyping Used For?

Genotyping is used to validate, monitor, or select for specific known genetic variants at scale. Understanding what genotyping is used for is key to deciding between DNA sequencing vs genotyping.

Genotyping is commonly applied when researchers need to validate, monitor, or select for specific known variants, including:

1. Agriculture & Breeding

  • Marker-assisted selection (MAS)
  • Trait validation in plant and animal breeding
  • Genomic selection (GS)
  • Hybrid verification and seed purity testing

2. Biomedical & Clinical Research

  • Disease-associated variant screening
  • Pharmacogenomics studies
  • Population genetics analysis
  • Monitoring transmission patterns of genetic risk factors

3. Research & Quality Control

  • Strain identification
  • Sample authentication
  • Genetic background confirmation

Because genotyping focuses on predefined variants, it is the preferred method when the objective is screening or validation rather than discovery. If novel mutations must be identified, sequencing becomes the more appropriate approach.

What Is Sequencing?

DNA sequencing is the process of determining the exact order of the four nucleotides, adenine (A), thymine (T), cytosine (C), and guanine (G), in a DNA molecule. By reading the precise nucleotide sequence of a gene, targeted region, or entire genome, sequencing reveals the complete genetic information of a sample.

In the context of genotyping vs sequencing, DNA sequencing provides a comprehensive view of genetic variation, while genotyping focuses only on detecting predefined variants. This broader scope makes sequencing essential when mutation discovery or full genomic characterization is required.

How Does DNA Sequencing Work?

DNA sequencing involves several key steps:

  • DNA Extraction: Genetic material is isolated from the sample.
  • Library Preparation: DNA is fragmented and adapters are added for amplification and detection.
  • Amplification & Sequencing Reaction: Platforms such as next-generation sequencing (NGS) read millions to billions of DNA fragments in parallel.
  • Data Analysis: Bioinformatic tools assemble and interpret the sequence data to identify variants, mutations, or structural changes.

Modern sequencing technologies enable whole-genome sequencing (WGS), whole-exome sequencing (WES), and targeted panel sequencing. Short-read platforms (Illumina) deliver high accuracy at low cost per base, while long-read platforms (Oxford Nanopore, PacBio) resolve structural variants and repetitive regions that short reads cannot. Compared to genotyping, sequencing requires more computational analysis but delivers higher resolution and discovery potential.

What Is DNA Sequencing Used For?

DNA sequencing is used to discover novel variants, characterize whole genomes, and study genetic mechanisms in detail. Understanding what DNA sequencing is used for helps clarify the difference in the DNA sequencing vs genotyping decision.

Sequencing is widely applied in:

Biomedical Research

  • Identifying disease-causing mutations
  • Cancer genomics and tumor profiling
  • Rare disease diagnostics

Clinical & Personalized Medicine

  • Pharmacogenomics
  • Precision oncology
  • Inherited disorder screening

Agriculture & Environmental Science

  • Trait discovery in breeding programs
  • Pathogen identification
  • Microbial and metagenomic studies

Because sequencing uncovers both known and novel variants, it is the preferred method when researchers need comprehensive genetic insight rather than targeted variant detection.

What Is Genotyping by Sequencing (GBS)?

Genotyping by sequencing (GBS) is a reduced-representation sequencing method that simultaneously discovers and genotypes thousands of SNPs across many samples. Unlike traditional PCR genotyping, which targets predefined loci, GBS combines restriction enzyme digestion with next-generation sequencing (NGS) to simultaneously discover and genotype thousands of SNPs across many samples.

In the broader genotyping vs sequencing comparison, GBS represents a hybrid approach. It uses DNA sequencing technology but focuses on a subset of the genome rather than delivering full whole-genome coverage. This allows researchers to balance variant discovery with scalability.

GBS is especially useful for:

  • SNP discovery
  • De novo genome assembly
  • High-density genetic mapping
  • Population genomics
  • Research involving non-model organisms

Although more comprehensive, sequencing requires greater computational resources, higher costs, and longer turnaround times. It is often used in early-stage research or when genome-wide insights are needed.

How Does Genotyping by Sequencing Work?

GBS typically involves:

  • Restriction enzyme digestion to reduce genome complexity
  • Adapter ligation and barcode tagging for multiplexing samples
  • Next-generation sequencing (NGS) of selected fragments
  • Bioinformatic analysis to identify SNPs and genotype samples

Genotyping vs Sequencing: Key Differences at a Glance

While genotyping and sequencing are both essential tools in modern genomics, they differ in scope, detail, and application. Understanding these differences helps researchers select the most efficient and cost-effective method for their study.

FeaturePCR GenotypingGenotyping by Sequencing
PurposeScreen known SNPs/IndelsDiscover and profile genome-wide variants
CostLow (especially per data point)High (especially for high-depth coverage)
SpeedFast (simple analysis pipeline)Slower (complex bioinformatics)
Data VolumeTargeted, focused outputHigh volume, requiring storage/analysis
ThroughputHigh (thousands of samples/day)Moderate (fewer samples, more depth)
Best forMarker-assisted selection, validation, routine screeningDiscovery research, rare disease, whole-genome studies

When to Choose Genotyping vs Sequencing

Choose genotyping when:

  • Variants of interest are already known
  • Large populations need to be screened efficiently
  • Cost and speed are priorities
  • Routine validation or breeding selection is required

Choose DNA sequencing when:

  • Novel mutations must be identified
  • Structural or rare variants are important
  • Comprehensive genomic analysis is required
  • Discovery-driven research is the goal

Advantages of PCR Genotyping

  1. Efficiency PCR-based systems like PACE allow for extremely fast processing of large sample sets. With platforms like the 3CR GeneArrayer, researchers can process thousands of reactions per day.
  2. Cost-Effectiveness When working with a known set of markers (e.g. 1–100 SNPs), PCR genotyping dramatically lowers per-sample and per-marker costs compared to sequencing.
  3. Simplicity PCR genotyping does not require extensive data analysis. A simple fluorescence readout indicates genotype, making the process ideal for labs without dedicated bioinformatics support.
  4. Flexibility Custom primers can be developed from SNP-containing sequences without needing a full reference genome. PACE chemistry works well even in non-model species.
  5. High Sensitivity and Specificity Allele-specific PCR is well-suited to validate marker-trait associations with minimal false positives, which is critical in breeding programs.

Advantages of Genotyping by Sequencing

  1. Genome-Wide Discovery
    GBS methods allow detection of novel variants, including rare SNPs, structural variants, and insertions/deletions.
  2. High Marker Density
    Sequencing provides access to thousands or millions of markers, ideal for fine mapping or detailed population structure analysis.
  3. Broad Applications
    Sequencing is useful for evolutionary studies, de novo genome assembly, and any situation where prior marker knowledge is lacking.
  4. Future-Proofing
    Once sequencing data is generated, it can be reused or reanalyzed in the future for different research questions.

When to Choose Genotyping Over Sequencing

Genotyping is the preferred approach when speed, cost-efficiency, and targeted variant detection are key. PCR-based genotyping delivers reliable results without the depth or expense of full sequencing. It is ideal when:

  • The variants are already known, and the goal is to confirm their presence or absence.
  • Cost per data point is important, and large-scale screening must remain affordable.
  • High-throughput testing is required, such as analyzing many samples in a short time.
  • Real-time decision-making is critical, for example in breeding programs or diagnostics.
  • Sample input is limited or low quality, including crude materials like leaf punches or animal hair.

Case Study: Peanut Breeding at NC State University

At North Carolina State University’s Peanut Breeding & Genetics Program, researchers used PCR genotyping with PACE to streamline cultivar development. By targeting SNPs linked to key traits, they reduced genotyping time and cost, accelerating trait selection and variety release. Read more about their development pipeline here.

When to Choose Sequencing Over Genotyping

Use genotyping-by-sequencing when:

  • You’re working with non-model species with unknown markers
  • You need to build genetic maps or conduct association studies
  • You need to detect a broad spectrum of genomic variation
  • You’re conducting basic or exploratory research

Integration of Both Approaches

The most efficient research strategies often combine sequencing for discovery with PCR genotyping for validation and large-scale screening. This complementary use plays to the strengths of each method:

  • Use GBS to discover markers and identify candidate SNPs
  • Then use PCR genotyping (e.g. PACE) to validate and screen those markers in large populations

This pipeline supports robust, cost-effective breeding strategies where sequencing sets the stage and PCR delivers the practical results.

Scalable PCR Genotyping for Every Lab

3CR Bioscience’s PACE® technology offers researchers a fast, accurate, and scalable way to perform SNP genotyping at any throughput. The chemistry is designed for flexibility across crops, species, and sample types:

  • Compatible with crude DNA and RNA inputs
  • Multiplexing up to 4 targets per reaction
  • Supports real-time or endpoint detection
  • Interoperable with KASPâ„¢ and Amplifluor systems

PACE 2.0 provides enhanced signal clarity and tight clustering, even from challenging DNA sources, PACE Multiplex allows multiple assays per reaction, while PACE OneStep RT-PCR enables direct RNA-to-genotype workflows.

Automating Genotyping with 3CR’s GeneArrayer Platform

To further improve throughput and reproducibility, 3CR offers a full suite of automation tools:

  • GeneExtract: Fast, high-yield DNA extraction
  • GeneArrayer: Automated PCR plate setup for high throughput
  • GeneCycler: Optimised thermal cycling
  • GeneScanner: High-resolution fluorescence detection

These tools work together to reduce hands-on time, standardise results, and cut costs for genotyping at scale.

Final Thoughts

Choosing between genotyping and sequencing depends on your goals, sample size, and budget. For focused, high-throughput screening of known variants, PCR genotyping remains the most efficient choice. For discovery-driven or genome-wide research, sequencing is unmatched in depth and detail.

At 3CR Bioscience, we help researchers build cost-effective, fit-for-purpose genotyping strategies with robust assay design, validated chemistry, and streamlined instrumentation.

Need help deciding between PCR genotyping and sequencing for your project? Contact us at support@3crbio.com — we’re here to help you choose the right tool for the job.


Frequently Asked Questions

What is the main difference between genotyping and sequencing?

Genotyping detects known genetic variants at predefined positions, while sequencing reads the exact nucleotide order of a DNA region or entire genome to reveal both known and novel variants. Genotyping is faster and cheaper at scale; sequencing delivers more comprehensive information.

Is genotyping cheaper than sequencing?

Yes. PCR-based genotyping typically costs cents per data point and scales linearly with sample number, while whole-genome or whole-exome sequencing usually costs tens to hundreds of dollars per sample plus bioinformatics overhead. The cost advantage grows as sample numbers increase.

When should I use PCR genotyping instead of sequencing?

Use PCR genotyping when the variants of interest are already known, when large populations need to be screened, when turnaround time and cost matter, or when sample input is limited or low quality. Marker-assisted selection in plant breeding is a typical example.

What is genotyping by sequencing (GBS) used for?

GBS is used for SNP discovery, de novo genetic map construction, population genomics, and research in non-model species without a reference genome. It captures a representative subset of the genome through restriction enzyme digestion combined with next-generation sequencing.

Does whole genome sequencing replace genotyping?

Not for most production-scale workflows. Even as sequencing costs fall, PCR genotyping remains faster, cheaper per data point, and simpler to analyze for known-marker screening. Many programs use sequencing to discover markers and PCR genotyping to deploy them at scale.

What is the best method for marker-assisted selection?

PCR-based SNP genotyping with chemistries like PACE® is the standard for marker-assisted selection. It delivers high accuracy on known markers, tolerates crude DNA inputs, scales to thousands of samples per day, and integrates cleanly with existing breeding workflows.


Case Study: Peanut Breeding at NC State University

At North Carolina State University’s Peanut Breeding & Genetics Program, researchers used PCR genotyping with PACE to streamline cultivar development. By targeting SNPs linked to key traits, they reduced genotyping time and cost, accelerating trait selection and variety release. Read more about their development pipeline in our case study.

MORE POSTS

PACE® Genotyping Enables Marker Development for Avocado Skin Colour: Insights from a New GWAS Study
Learn how PACE genotyping is helping avocado breeders accelerate marker-assisted selection for commercially valuable skin colour traits.
Early, Accurate & Scalable Sex Determination with PACE Genotyping
Unlock faster, smarter breeding decisions with early sex determination powered by scalable PACE genotyping.
New research highlights the power of PACE® genotyping in identifying disease resistance in watermelon
What if breeders could identify disease-resistant watermelon plants before they even grow - this study shows how PACE® genotyping makes it possible.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Resolve Genotyping Challenges. With One Practical Guide.

From failed amplification to scattered cluster plots — this guide provides structured, expert-backed solutions for the 7 most common PACE® genotyping issues.

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
I’d like to sign up for the newsletter

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.